Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas

Experimental and Clinical Endocrinology and Diabetes

Volumn 116, Issue 10, 2008, Pages 625-628

  Buchbinder, S ^a   Bierhaus, A ^a   Zorn, M ^a   Nawroth, P P ^a   Humpert, P ^a   Schilling, Tobias ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

AIP; Germline mutations; Hormone secreting and non secreting adenoma

Indexed keywords

ADENINE; ARGININE; AROMATIC HYDROCARBON RECEPTOR INTERACTING PROTEIN; BINDING PROTEIN; CYTOSINE; GUANINE; HISTIDINE; THYMINE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ACROMEGALY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GERMANY; GONADOTROPH ADENOMA; GROWTH HORMONE SECRETING ADENOMA; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; HYPOPHYSECTOMY; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; NONFUNCTIONING PITUITARY ADENOMA; PRIORITY JOURNAL; PROLACTINOMA; STOP CODON;

ADENOMA; ADULT; AGE OF ONSET; AGED; AMINO ACID SUBSTITUTION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PITUITARY HORMONES; PITUITARY NEOPLASMS;

EID: 57049102370     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1065366     Document Type: Article

References (18)

1. Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endoc Relat Cancer 2001; 8: 287-305
2. Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, Tamagn G, Cazabat L, Bours V, Brue T, Enjalbert A, Beckers A. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 2007; 92: 1952-1955
3. Beckers A, Daly AF. The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 2007; 157: 371-382
4. Carlson DB, Perdew GH. A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J Biochem Mol Toxicol 2002; 16: 317-325
5. Cazabat L, Libè R, Perlemoine K, René-Corail F, Burnichon N, Gimenez-Roqueplo AP, Dupasquier-Fediaevsky L, Bertagna X, Clauser E, Chanson P, Bertherat J Raffin-Sanson ML. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. Eur J Endocrinol 2007; 157: 1-8
6. Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G, Raverot G, Barlier A, Herder W De, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabaté MI, Bertagna X, Garcia Basavilbaso N, Stalldecker G, Colao A, Ferolla P, Wémeau JL, Caron P, Sadoul JL, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Montañana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT, Beckers A. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 2007; 92: 1891-1896
7. Georgitsi M, Karhu A, Winqvist R, Visakorpi T, Waltering K, Vahteristo P, Launonen V, Aaltonen LA. Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers. Br J Cancer 2007; 96: 352-356
8. Georgitsi M, Raitila A, Karhu A, Tuppurainen K, Mäkinen MJ, Vierimaa O, Paschke R, Saeger W, Luijt RB van der, Sane T, Robledo M, Menis E De, Weil RJ, Wasik A, Zielinski G, Lucewicz O, Lubinski J, Launonen V, Vahteristo P, Aaltonen LA. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. Proc Natl Acad Sci USA 2007; 104: 4101-4105
9. Iwata T, Yamada S, Mizusawa N, Golam HM, Sano T, Yoshimoto K. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas. Clin Endocrinol 2007; 66: 499-502
10. Kolluri SK, Weiss C, Koff A, Göttlicher M. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev 1999; 13: 1742-1753
11. Kuzhandaivelu N, Conf. YS, Inouye C, Yang WM, Seto E. XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res 1996; 24: 4741-4750
12. LaPres JJ, Glover E, Dunham EE, Bunger MK, Bradfield CA. ARA9 modifies agonist signaling through an increase in cytosolic aryl hydrocarbon receptor. J Biol Chem 2000; 275: 6153-6159
13. Naves LA, Daly AF, Vanbellinghen JF, Casulari LA, Spilioti C, Magalhães AV, Azevedo MF, Giacomini LA, Nascimento PP, Nunes RO, Rosa JW, Jaffrain-Rea ML, Bours V, Beckers A. Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene. Eur J Endocrinol 2007; 157: 383-391
14. Toledo RA, Lourenço DM, Liberman B, Cunha-Neto MB, Cavalcanti MG, Moyses CB, Toledo SP, Dahia PL. Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma. J Clin Endocrinol Metab 2007; 92: 1934-1937
15. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gündogdu S, Menis E De, Mäkinen MJ, Launonen V, Karhu A, Aaltonen LA. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006; 26: 1228-1230
16. Weiss C, Kolluri SK, Kiefer F, Göttlicher M. Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor. Exp Cell Res 1996; 226: 154-163
17. Wichers-Rother M, Hoven S, Kristof RA, Bliesener N, Stoffel-Wagner B. Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery. Exp Clin Endocrinol Diabetes 2004; 112: 323-327
18. Yu R, Bonert V, Saporta I, Raffel LJ, Melmed S. Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas. J Clin Endocrinol Metab 2006; 91: 5126-5129